Pirdonium bromide

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H30NO.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5123Q291S5, chemically known as 1,1-dimethyl-2-(((p-methyl-alpha-phenylbenzyl)oxy)methyl)piperidinium bromide but more generally known as pirdonium bromide, which bears US NIH Compound Identifier 3047852. European Medicines Agency schedules Pirdonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09901MIG. The term PIRDONIUM BROMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13). Most nations, for tariff and trade purposes, schedule pirdonium bromide under HS 29333999 and SITC 51574. As of Q4 2014, PIRDONIUM BROMIDE remains US FDA's Preferred Term for this commodity. Pirdonium bromide bears US NLM identifiers UMLS ID C1882393 and NCI Concept Code C66415. SMILES: CC1CCC(CC1)C(C2CCCCC2)OCC3CCCC[N+]3(C)C.[BR-].